Oric Pharmaceuticals
ORIC
ORIC
64 hedge funds and large institutions have $192M invested in Oric Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-12
Holders Change %
-15.79%
% of All Funds
1.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
6
Increased
21
Reduced
20
Closed
18
Calls
$1.04M
Puts
$190K
Net Calls
+$850K
Net Calls Change
+$431K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$11.1M |
| 2 |
2
Alkeon Capital Management
New York
|
$14.1M |
| 3 |
PM
3
Prosight Management
Dallas,
Texas
|
$6.95M |
| 4 |
MAM
4
Monaco Asset Management
Monaco
|
$3.28M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$9.11M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$9.47M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$23.7M |
| 3 |
3
BlackRock
New York
|
$4.7M |
| 4 |
UOC
4
UBS O'Connor
Chicago,
Illinois
|
$0 |
| 5 |
DCM
5
DAFNA Capital Management
Los Angeles,
California
|
$1.56M |
